Best Practices for Counseling Adolescents about the Etonogestrel Implant. 2020

Elise D Berlan, and Molly J Richards, and Carolina Sales Vieira, and Mitchell D Creinin, and Andrew M Kaunitz, and Ian S Fraser, and Alison Edelman, and Diana Mansour
Department of Pediatrics, Nationwide Children's Hospital, Columbus, OH, USA. Electronic address: Elise.berlan@nationwidechildrens.org.

Among young persons, ease of use, high efficacy, and high acceptability makes the etonogestrel contraceptive implant an important choice for this age group. Adolescent-friendly, patient-centered counseling considers the patient's cognitive development, the influence of friends and family, as well as their own preferences and values. Age-appropriate language, graphics, and models are useful to explain contraceptive options and relevant side effects. Effectiveness, reversibility, safety, noncontraceptive benefits, and side effects are important attributes and should be discussed when teens are choosing a contraceptive method. In this review we describe suggested best practices for counseling adolescents about the etonogestrel implant so they can make informed, prudent decisions about using this contraceptive method.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011253 Pregnancy in Adolescence Pregnancy in human adolescent females under the age of 19. Adolescent Pregnancy,Pregnancy, Adolescent,Pregnancy, Teenage,Preteen Pregnancy,Teenage Pregnancy,Teen Pregnancy,Adolescence, Pregnancy in,Adolescent Pregnancies,Pregnancies, Adolescent,Pregnancies, Preteen,Pregnancies, Teen,Pregnancies, Teenage,Pregnancy, Preteen,Pregnancy, Teen,Preteen Pregnancies,Teen Pregnancies,Teenage Pregnancies
D003267 Contraception Prevention of CONCEPTION by blocking fertility temporarily, or permanently (STERILIZATION, REPRODUCTIVE). Common means of reversible contraception include NATURAL FAMILY PLANNING METHODS; CONTRACEPTIVE AGENTS; or CONTRACEPTIVE DEVICES. Birth Control,Contraceptive Methods,Female Contraception,Fertility Control,Inhibition of Fertilization,Male Contraception,Contraception, Female,Contraception, Male,Contraceptions, Female,Contraceptions, Male,Contraceptive Method,Female Contraceptions,Fertilization Inhibition,Male Contraceptions
D003271 Contraceptive Agents, Female Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. Contraceptives, Female,Agents, Female Contraceptive,Female Contraceptive Agents,Female Contraceptives
D003376 Counseling The giving of advice and assistance to individuals with educational or personal problems.
D004343 Drug Implants Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug. Drug Implant,Drug Pellet,Pellets, Drug,Drug Pellets,Implant, Drug,Implants, Drug,Pellet, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D017135 Desogestrel A synthetic progestational hormone used often as the progestogenic component of combined oral contraceptive agents (ORAL CONTRACEPTIVES, COMBINED). 18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17alpha)-,13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol,Cerazette,Marvelon,Org-2969,13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol,Org 2969,Org2969,alpha-pregn-4-en-20-yn-17-ol, 13-Ethyl-11-methylene-18,19-dinor-17

Related Publications

Elise D Berlan, and Molly J Richards, and Carolina Sales Vieira, and Mitchell D Creinin, and Andrew M Kaunitz, and Ian S Fraser, and Alison Edelman, and Diana Mansour
May 2024, Contraception,
Elise D Berlan, and Molly J Richards, and Carolina Sales Vieira, and Mitchell D Creinin, and Andrew M Kaunitz, and Ian S Fraser, and Alison Edelman, and Diana Mansour
April 2011, Contraception,
Elise D Berlan, and Molly J Richards, and Carolina Sales Vieira, and Mitchell D Creinin, and Andrew M Kaunitz, and Ian S Fraser, and Alison Edelman, and Diana Mansour
January 2024, Pediatrics in review,
Elise D Berlan, and Molly J Richards, and Carolina Sales Vieira, and Mitchell D Creinin, and Andrew M Kaunitz, and Ian S Fraser, and Alison Edelman, and Diana Mansour
June 2017, Journal of pediatric and adolescent gynecology,
Elise D Berlan, and Molly J Richards, and Carolina Sales Vieira, and Mitchell D Creinin, and Andrew M Kaunitz, and Ian S Fraser, and Alison Edelman, and Diana Mansour
January 2011, International journal of adolescent medicine and health,
Elise D Berlan, and Molly J Richards, and Carolina Sales Vieira, and Mitchell D Creinin, and Andrew M Kaunitz, and Ian S Fraser, and Alison Edelman, and Diana Mansour
August 2001, Drug and therapeutics bulletin,
Elise D Berlan, and Molly J Richards, and Carolina Sales Vieira, and Mitchell D Creinin, and Andrew M Kaunitz, and Ian S Fraser, and Alison Edelman, and Diana Mansour
August 2018, American family physician,
Elise D Berlan, and Molly J Richards, and Carolina Sales Vieira, and Mitchell D Creinin, and Andrew M Kaunitz, and Ian S Fraser, and Alison Edelman, and Diana Mansour
March 1998, Primary care,
Elise D Berlan, and Molly J Richards, and Carolina Sales Vieira, and Mitchell D Creinin, and Andrew M Kaunitz, and Ian S Fraser, and Alison Edelman, and Diana Mansour
September 1985, Seminars in adolescent medicine,
Elise D Berlan, and Molly J Richards, and Carolina Sales Vieira, and Mitchell D Creinin, and Andrew M Kaunitz, and Ian S Fraser, and Alison Edelman, and Diana Mansour
May 2024, Issues in mental health nursing,
Copied contents to your clipboard!